Abstract | OBJECTIVE: METHOD: Eighteen patients with classic features of interstitial cystitis were enrolled in the study. Patients received 40 mL chondroitin sulfate, 0.2% instilled intravesically once a week for four weeks and then once a month for 12 months. At the same times, Quality of Life Improvement scores, voiding diaries, and pain and voiding indices were reviewed. RESULTS: Thirteen of 18 patients were followed for the entire 13-month study. Twelve of these patients responded to treatment within 3 to 12 weeks, on average. A total of 6/13 (46.2%) showed a good response, 2/13 (15.4%) had a fair response, and 4/13 (30.8%) had a partial response and 1/13 (7.7%) showed no response. CONCLUSION:
|
Authors | G Steinhoff, B Ittah, S Rowan |
Journal | The Canadian journal of urology
(Can J Urol)
Vol. 9
Issue 1
Pg. 1454-8
(Feb 2002)
ISSN: 1195-9479 [Print] Canada |
PMID | 11886599
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
|
Topics |
- Chondroitin Sulfates
(administration & dosage)
- Cystitis, Interstitial
(drug therapy)
- Female
- Humans
- Male
|